Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2008

View Archived Issues

Ascorbate demonstrates anticancer activity in vitro and in vivo

IL-21 immunologically active in patients with metastatic melanoma, renal cell carcinoma

Johnson & Johnson research into tryptase inhibitors continues with new compounds

PEG coating allows nanoparticles to penetrate the mucus barrier

Immunoglobulin intravenous appears safe over 48 weeks in CIDP patients

S-Methylisothiourea reduces cerebral ischemia damage in vivo

QseC signaling inhibition with LED-209 blocks bacterial vigilance

Novel p38 MAP kinase inhibitors synthesized at Palau Pharma

Growth hormone secretagogue BMS-606056 displays promising preclinical characteristics

Transgene and Roche modify clinical development program for TG-4001/R-3484

Eisai offers Q1 overview

Recent sanofi-aventis patent discloses new analgesic agents

Novel therapeutic agents for glaucoma reported in recent Allergan patents

Arpida submits NDS for intravenous iclaprim in Canada

Recent patents disclose novel antiinfective agents

Overall survival results reported in Erbitux phase III lung cancer study

Shionogi acquires U.S.-based Sciele Pharma

sanofi-aventis acquires Symbion

EMEA approves Intelence for the treatment of HIV

Taxotere Injection approved in Japan for prostate cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...